Long-Term Assets: The sum of all assets classified as non-current.
Avalyn Pharma Inc. (AVLN) had Long-Term Assets of 5.68M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-26.87M |
|
-- |
|
-- |
|
27.91M |
|
-27.91M |
|
1.04M |
|
-26.87M |
|
-26.87M |
|
-26.87M |
|
-26.87M |
|
-26.87M |
|
-26.87M |
|
-27.91M |
|
-28.08M |
|
1.23M |
|
1.23M |
|
-21.83 |
|
-21.83 |
|
| Balance Sheet Financials | |
129.99M |
|
1.26M |
|
|
Long-Term Assets |
5.68M |
135.66M |
|
11.79M |
|
14.81M |
|
388.12M |
|
399.91M |
|
-264.25M |
|
-264.25M |
|
-264.25M |
|
1.23M |
|
| Cash Flow Statement Financials | |
-29.89M |
|
55.02M |
|
14.86M |
|
52.31M |
|
92.31M |
|
39.99M |
|
1.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.03 |
|
-- |
|
-- |
|
-0.06 |
|
-0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.17% |
|
10.17% |
|
-19.81% |
|
10.77% |
|
-214.48 |
|
-24.55 |
|
-24.29 |
|